Pharmaceutical Technology21 天
Sovateltide by Pharmazz for Hypoxic-Ischemic Encephalopathy: Likelihood of Approval
Sovateltide is under clinical development by Pharmazz and currently in Phase I for Hypoxic-Ischemic Encephalopathy. According to GlobalData, Phase I drugs for Hypoxic-Ischemic Encephalopathy does not ...
emjreviews.com27 天
Machine Learning Advances Prognosis in Hypoxic-Ischemic Encephalopathy
MACHINE LEARNING models incorporating MRI-based measures improve the accuracy of predicting neurodevelopmental outcomes in neonates with hypoxic-ischemic encephalopathy (HIE), surpassing the ...